z-logo
open-access-imgOpen Access
Correction: Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathways
Author(s) -
David W. Greening,
Sze Ting Lee,
Hong Ji,
Richard J. Simpson,
Angela Rigopoulos,
Carmel Murone,
Catherine Fang,
Sylvia Gong,
Graeme O’Keefe,
Andrew M. Scott
Publication year - 2016
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.9855
Subject(s) - cetuximab , bevacizumab , colorectal cancer , medicine , profiling (computer programming) , oncology , bioinformatics , cancer research , biology , computer science , chemotherapy , cancer , operating system

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom